Literature DB >> 22190588

Adverse events in Spanish intensive care units: the SYREC study.

Paz Merino1, Joaquín Álvarez, Mari Cruz Martín, Ángela Alonso, Isabel Gutiérrez.   

Abstract

OBJECTIVE: To estimate the incidence and characteristics of adverse events (AEs) and no-harm events (NHEs) in critically ill patients.
DESIGN: Observational, prospective, 24-h cross-sectional study with self-reporting.
SETTING: Seventy-nine intensive care units at 76 hospitals. MEASUREMENTS: Number of events, risk of AEs and NHEs, types of incidents, severity and avoidability of incidents.
RESULTS: A total of 1017 patients were included in the study; 591 (58%) were affected by one or more incidents. Of the 1424 valid incidents, 943 (66%) were NHEs and 481 (34%) were AEs. The individual risk of suffering at least one incident was 62%, at least one NHE 45% and at least one AE 29%. The median number of incidents, NHEs and AEs was 6, 3 and 2 per 100 patient-hours, respectively. Seventy-four per cent of the incidents were related to medication (24%), equipment (15%), nursing care (14%), accidental withdrawal of vascular accesses and catheters (10%) or airways and mechanical ventilation (10%). AEs resulted in temporary damage in 29% and in permanent damage or damage that compromised patients' lives or contributed to their death in 4%. Incidents were avoidable in 79% of cases (90% in NHEs and 60% in AEs, P < 0.05).
CONCLUSIONS: The individual risk for incidents in critical patients is high. Many incidents did not harm patients, some caused damage and a few were related to the patient's death. Most incidents were considered avoidable.

Entities:  

Mesh:

Year:  2011        PMID: 22190588     DOI: 10.1093/intqhc/mzr083

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  8 in total

1.  Understanding medical errors and adverse events in ICU patients.

Authors:  Maité Garrouste-Orgeas; Hans Flaatten; Rui Moreno
Journal:  Intensive Care Med       Date:  2015-08-07       Impact factor: 17.440

2.  What's new for patient safety in the ICU?

Authors:  Maité Garrouste-Orgeas; Andreas Valentin
Journal:  Intensive Care Med       Date:  2013-07-09       Impact factor: 17.440

3.  Ensuring Accurate, Timely Medication Orders and Reducing Errors: Assessment of a Read-Back Tactic.

Authors:  Jonathan F Mailman; Jeffrey Betcher; William Semchuk
Journal:  Can J Hosp Pharm       Date:  2017-10-31

4.  Feasibility and utility of the use of real time random safety audits in adult ICU patients: a multicentre study.

Authors:  M Bodí; M Olona; M C Martín; R Alceaga; J C Rodríguez; E Corral; J M Pérez Villares; G Sirgo
Journal:  Intensive Care Med       Date:  2015-04-14       Impact factor: 17.440

5.  Expectations, training and evaluation of intensive care staff to an interprofessional simulation course in Germany - Development of a relevant training concept.

Authors:  Markus Flentje; Lars Friedrich; Hendrik Eismann; Wolfgang Koppert; Heiner Ruschulte
Journal:  GMS J Med Educ       Date:  2020-02-17

6.  A study of medication errors during the prescription stage in the pediatric critical care services of a secondary-tertiary level public hospital.

Authors:  Lorena Michele Brennan-Bourdon; Alan O Vázquez-Alvarez; Jahaira Gallegos-Llamas; Manuel Koninckx-Cañada; José Luis Marco-Garbayo; Selene G Huerta-Olvera
Journal:  BMC Pediatr       Date:  2020-12-05       Impact factor: 2.125

7.  How do doctors and nurses manage delirium in intensive care units? A qualitative study using focus groups.

Authors:  Domingo Palacios-Ceña; José Miguel Cachón-Pérez; Rosa Martínez-Piedrola; Javier Gueita-Rodriguez; Marta Perez-de-Heredia; Cesar Fernández-de-las-Peñas
Journal:  BMJ Open       Date:  2016-01-29       Impact factor: 2.692

8.  Epidemiology of Adverse Events and Medical Errors in the Care of Cardiology Patients.

Authors:  Yoshinori Ohta; Izumi Miki; Takeshi Kimura; Mitsuru Abe; Mio Sakuma; Kaoru Koike; Takeshi Morimoto
Journal:  J Patient Saf       Date:  2019-09       Impact factor: 2.844

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.